Methylation of cation–chloride cotransporters NKCC1 and KCC2 in patients with juvenile myoclonic epilepsy
The etiology of juvenile myoclonic epilepsy (JME) is still unknown and the process of elaboration of multiple genetic mechanisms is ongoing. The aim of this study was to investigate the potential role of NKCC1 (SCL12A2) and KCC2 (SCL12A5) in JME by comparing their DNA methylation status in patients with JME versus healthy controls. Forty-nine patients with JME and 39 healthy individuals were compared for DNA methylation at the 5CpG islands. A total of 71 (81%) samples were found to have methylation in the NKCC1 gene, 36 (73%) from patients and 35 (90%) from healthy individuals. Out of the KCC2 samples, 50 (57%) were found to have methylation, 33 (67%) from patients and 17 (44%) from healthy individuals. In patients with JME, methylation of NKCC1 (73%) was lower than its methylation in the controls (90%) (p = 0.047). On the other hand, methylation of KCC2 in patients with JME (67%) was greater than the methylation in the controls (44%) (p = 0.022). Twenty-eight patients were treated with VPA and ongoing medications were not found to be associated with methylation (p > 0.05). In the present study, we determined significantly lower NKCC1 DNA methylation and significantly higher KCC2 DNA methylation levels in patients with JME compared with the healthy controls. This implies that NKCC1 expression can be higher and KCC2 expression can be reduced in affected people. Further studies that investigate the potential effect of DNA methylation mechanisms regulating gene expression on seizure activity and how they change JME network activity will be helpful.
KeywordsJuvenile myoclonic epilepsy Epigenetic DNA methylation Cation–chloride cotransporters NKCC1 (SCL12A2), KCC2 (SCL12A5)
Compliance with ethical standards
The study was approved by the Ethics Committee of Antalya Education and Research Hospital.
Conflict of interest
The authors declare that there are no conflicts of interest.
- 2.Dedei Daryan M, Güveli BT, Baslo SA, Mulhan K, Sarı H, Balçık ZE, Ataklı D (2018) Prevalence and clinical characteristics of headache in juvenile myoclonic epilepsy: experience from a tertiary epilepsy center. Neurol Sci 39(3):519–525. https://doi.org/10.1007/s10072-017-3232-y CrossRefGoogle Scholar
- 5.Kobow K, Blümcke I (2018) Epigenetics in epilepsy. Neurosci Lett 667:40–46. https://doi.org/10.1016/j.neulet.2017.01.012
- 10.Hirose C (2014) Mutant GABAA receptor subunits in genetic (idiopathic) epilepsy. Prog Brain Res 213:55–85. https://doi.org/10.1016/B978-0-444-63326-2.00003-X CrossRefGoogle Scholar
- 16.Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology. 2005–2009. Epilepsia 51(4):676–685. https://doi.org/10.1111/j.1528-1167.2010.02522.x CrossRefGoogle Scholar
- 21.Taskıran E, Bebek N (2015) Drug resistance and resistance mechanisms in epilepsy. Epilepsi 21(2):43–53. https://doi.org/10.5505/epilepsi.2015.50570
- 23.Li X, Zhou J, Chen Z, Chen S, Zhu F (2008) Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE). Brain Res 1221:141–146. https://doi.org/10.1016/j.brainres.2008.04.047 CrossRefGoogle Scholar
- 26.Lösher W, Puskarjov M, Kaila K (2013) Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Neuropharmacology 69:62–74. https://doi.org/10.1016/j.neuropharm.2012.05.045
- 28.Belhedi N, Perroud N, Karege F, Vessaz M, Malafosse A, Salzmann A (2014) Increased CPA6 promoter methylation in focal epilepsy and in febrile seizures. Epilepsy Res 108:144–148. https://doi.org/10.1016/j.eplepsyres.2013.10.007
- 29.Illingworth R, Kerr A, Desousa D et al (2008) A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 6(1):e22. https://doi.org/10.1371/journal.pbio.0060022